ASSOBRAFIR Ciência
https://assobrafirciencia.org/article/5dd540060e88251249c8fca6
ASSOBRAFIR Ciência
Artigo Original

Correlações entre o índice BODE e variáveis máximas de esforço em pacientes com DPOC

Correlation between the BODE index and variables of maximal exercise capacity in patients with COPD

Vinicius Cavalheri, Leandro Cruz Mantoani, Carlos Augusto Camillo, Fabio Pitta

Downloads: 5
Views: 990

Resumo

Introdução: Tanto o índice BODE quanto o pico de consumo de oxigênio (VO2 pico), uma das variáveis máximas de esforço, são preditores de morbidade e mortalidade de pacientes com doença pulmonar obstrutiva crônica (DPOC). Contudo, pouco se conhece sobre associações entre o índice BODE e variáveis máximas de esforço. Objetivos: Investigar correlações entre variáveis máximas de esforço e o índice BODE existentes em pacientes com DPOC. Métodos: Sessenta pacientes com DPOC (32 homens), com volume expiratório forçado no primeiro segundo (VEF1) 46±16%predito e idade 66±8anos foram submetidos a um teste cardiopulmonar máximo de esforço. Neste, foram coletados dados de potência máxima (Wmax), VO2 pico, volume minuto máximo (VEmax), frequência cardíaca máxima (FCmax), saturação periférica de oxigênio no repouso (SpO2 rep), no final (SpO2 f) e na fase de recuperação (SpO2 rec). Para caracterização da amostra e cálculo do índice BODE, os pacientes também foram submetidos às avaliações de função pulmonar (espirometria, com determinação do VEF1 ), dispneia percebida (escala modificada do Medical Research Council) e teste da caminhada de 6 minutos. Associações foram analisadas por meio de coeficientes de correlação simples (Pearson ou Spearman). Resultados: Correlações moderadas foram encontradas entre índice BODE com a Wmax, VO2 pico, VEmax, FCmax, SpO2 rep, SpO2 f e SpO2 rec (-0,27 ≤ r ≤ -0,51; p≤0,05 para todas). SpO2 rep e SpO2 rec correlacionaram-se com VO2 pico (r = 0,34 e 0,33, respectivamente; p=0,02 para ambos) e com a Wmax (r = 0,35 e 0,29, respectivamente; p=0,03). Conclusão: Melhor prognóstico de morbidade e mortalidade avaliado pelo índice BODE está moderadamente correlacionado com melhor capacidade máxima de esforço, oxigenação e recuperação após estresse máximo de pacientes com DPOC.

Palavras-chave

Doença Pulmonar Obstrutiva Crônica; Teste de esforço; Espirometria; Mortalidade

Abstract

Background: Both the BODE index and the peak rate of oxygen uptake (VO2 peak), one of the variables of maximal exercise capacity, are predictors of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD). However, little is known about associations between the BODE index and variables of maximal exercise capacity. Objectives: To investigate correlations between variables of maximal exercise capacity and the BODE index in patients with COPD. Methods: Sixty patients with COPD (32 men), with forced expiratory volume in one second (FEV1 ) 46±16%predicted and age 66±8 years underwent a maximal cardiopulmonary exercise test (CPET). During the CPET measures were collected of: maximum workload (Wmax), VO2 peak, maximum minute ventilation (VEmax), maximal heart rate (HRmax), peripheral oxygen saturation at rest (SpO2 rest), at the end of the test (SpO2 end) and at recovery (SpO2 rec). In order to characterize the population and calculate the BODE index, patients were also submitted to assessment of lung function (spirometry, with FEV1 measurement), self-reported dyspnoea (Medical Research Council scale, modified version) and 6-minute walking distance. Pearson or Spearman correlation coefficients were used to verify possible associations. Results: The BODE index correlated with Wmax, VO2 peak, VEmax, HRmax, SpO2 rest, SpO2 end e SpO2 rec (-0.27 ≤ r ≤ -0.51; p≤0.05 for all). Regarding correlations amongst variables of maximal exercise capacity, the SpO2 rest and SpO2 rec correlated with VO2 peak (r = 0.34 and 0.33, respectively; p=0.02 for both) and with the Wmax (r = 0.35 and 0.29, respectively; p=0.03). Conclusions: Better morbidity and mortality prognostic values, as measured by the BODE index, are moderately related to maximal exercise capacity, oxygen saturation and recovery after maximal stress.

Keywords

Chronic Obstructive; Pulmonary Disease; Exercise test; Spirometry; Mortality

Referências

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015 [Internet] [cited 2015 May 12]. Available from: http://www.goldcopd.org/.

2. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008 Apr 1;177(7):743-51.

3. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Feb 23;2:CD003793.

4. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003 Feb 15;167(4):544-9.

5. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005-12.

6. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005 Dec;128(6):3810-6.

7. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J. 2005 Oct;26(4):630-6.

8. Mantoani LC, Hernandes NA, Guimaraes MM, Vitorasso RL, Probst VS, Pitta F. Does the BODE index reflect the level of physical activity in daily life in patients with COPD? Rev Bras Fisioter. 2011 Mar-Apr;15(2):131-7.

9. Regueiro EM, Di Lorenzo VA, Basso RP, Pessoa BV, Jamami M, Costa D. Relationship of BODE Index to functional tests in chronic obstructive pulmonary disease. Clinics (Sao Paulo). 2009;64(10):983-8.

10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38.

11. Pereira CAC, Barreto SP, Simões JG, Pereira FWL, Gerstler JG, Nakatani J. Valores de referência para a espirometria em uma amostra da populaçäo brasileira adulta / Reference values for spirometry in Brazilian adults. J Bras Pneumol 1992 Mar;18(1):10-22.

12. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7.

13. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008 Dec;34(12):1008-18.

14. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77.

15. Probst VS, Troosters T, Pitta F, Decramer M, Gosselink R. Cardiopulmonary stress during exercise training in patients with COPD. Eur Respir J. 2006 Jun;27(6):1110-8.

16. Liu SF, Chin CH, Wang CC, Lin MC. Correlation between serum biomarkers and BODE index in patients with stable COPD. Respirology. 2009 Sep;14(7):999-1004.

17. Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med. 2009 Oct;103(10):1572-9.

18. Cardoso F, Tufanin AT, Colucci M, Nascimento O, Jardim JR. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study. Chest. 2007 Aug;132(2):477-82.

19. Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, et al. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003 May;123(5):1401-7.

20. Mathur RS, Revill SM, Vara DD, Walton R, Morgan MD. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax. 1995 Aug;50(8):829-33.

5dd540060e88251249c8fca6 assobrafir Articles
Links & Downloads

ASSOBRAFIR Ciência

Share this page
Page Sections